Nephros Inc
$ 2.88
-1.03%
14 Apr - close price
- Market Cap 30,974,800 USD
- Current Price $ 2.88
- High / Low $ 2.98 / 2.78
- Stock P/E 26.45
- Book Value 0.96
- EPS 0.11
- Next Earning Report 2026-05-21
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.06 %
- ROE 0.13 %
- 52 Week High 6.42
- 52 Week Low 1.64
About
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
Analyst Target Price
$7.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-05 | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-03-05 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-07 | 2023-11-08 | 2023-08-09 | 2023-05-10 |
| Reported EPS | 0.01 | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 | -0.03 |
| Estimated EPS | -0.01 | -0.02 | -0.01 | -0.005 | -0.015 | -0.02 | -0.01 | -0.04 | -0.02 | -0.06 | -0.05 | -0.02 |
| Surprise | 0.02 | 0.05 | 0.03 | 0.055 | 0.045 | 0.04 | -0.02 | 0.02 | -0.04 | 0.04 | 0.01 | -0.01 |
| Surprise Percentage | 200% | 250% | 300% | 1100% | 300% | 200% | -200% | 50% | -200% | 66.6667% | 20% | -50% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-21 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NEPH
2026-04-01 21:16:00
Nephros, Inc. announced an expansion of its water safety support capabilities, offering consulting services for Water Management Programs (WMPs) after its Director of Business Development, Brianne McGuire, earned the ASSE 12080 Legionella Water Safety and Management Specialist Certification. This allows Nephros to provide structured frameworks for identifying water-quality risks and implementing control measures, enhancing its services beyond filtration solutions. The company believes this new offering will create additional value for customers while opening a new avenue for revenue generation through chargeable consulting.
2026-04-01 20:40:40
Nephros, Inc. announced an expansion of its water safety capabilities, offering consultative support to facilities reducing waterborne pathogen risk. This follows Brianne McGuire, Director of Business Development, earning the ASSE 12080 Legionella Water Safety and Management Specialist Certification. The company will now provide Water Management Program development services, aiming to create value for customers and generate new revenue.
2026-04-01 16:09:55
Nephros, Inc. has expanded its water safety support capabilities by gaining ASSE 12080 Legionella Water Safety and Management Specialist Certification through Brianne McGuire, Director of Business Development. This certification allows Nephros to offer consultative support and direct Water Management Program (WMP) development services to healthcare facilities and other complex buildings. The company believes this new offering will create additional value for customers while also generating new revenue through chargeable consulting services, strengthening its overall value proposition.
2026-04-01 15:10:41
Nephros, Inc. announced an expansion of its water safety support capabilities, offering Water Management Program (WMP) development services to healthcare facilities and other complex buildings. This new offering follows Brianne McGuire, Director of Business Development, earning the ASSE 12080 Legionella Water Safety and Management Specialist Certification and is expected to create additional value for customers and generate new revenue. The company believes this will strengthen its overall value proposition and advance water safety and quality.
2026-04-01 14:09:49
Nephros, Inc. has expanded its water safety capabilities by offering ASSE 12080 certified Water Management Program (WMP) planning expertise, following the certification of its Director of Business Development, Brianne McGuire. This new service will allow Nephros to provide consultative support and WMP development to healthcare facilities and other complex buildings, aiming to reduce waterborne pathogen risk. The company anticipates this will enhance its customer value proposition, generate new revenue, and deepen its engagement in facilities' decision-making processes regarding water safety.
2026-04-01 14:09:38
This Simply Wall St report provides a comprehensive stock analysis for Nephros, Inc. (NEPH), a commercial-stage company specializing in water filtration solutions. The analysis details the company's valuation, future growth prospects, past performance, financial health, and dividend information, while also including analyst price targets and recent news. It highlights NEPH's current undervaluation and strong past earnings growth but notes risks associated with its market capitalization.
